PATENT CLAIM ANALYSIS

Application Number: 16223925
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["546", "119000"]

Abstract:
The invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.

Claim (Index 15):
The method according to  claim 14  for the treatment and/or prophylaxis of asthma, rheumatoid arthritis, inflammatory bowel disease, chronic obstructive pulmonary disease, acute respiratory distress syndrome, cystic fibrosis, osteoarthritis, polymyalgia rheumatica, giant cell arteritis, Sj\u00f6gren syndrome, Duchenne muscular dystrophy, vasculitis, Beh\u00e7et's disease, ulcerative colitis and/or Crohn's disease.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.19444
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16223845', '14409133', '13522823', '13272079', '12307526']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7833474760970018
- 35 USC 102 Novelty (BERT): 0.570219297818972
- Combined Prediction Score: 0.7620346582691989
- Mean Citation Score: 346.2803560000001
- Max Citation Score: 450.94534
- Similarity Product: 389.44658960445054

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test